Navigation Links
Auxilium Pharmaceuticals to Present at the 2012 Barclays Capital Global Healthcare Conference
Date:3/8/2012

ctelion Pharmaceuticals Ltd. has development and commercial rights for XIAFLEX in Australia, Brazil, Canada and Mexico. Ferring International Center S.A. markets Testim in the EU and Paladin Labs Inc. markets Testim in Canada. Auxilium has three projects in clinical development. XIAFLEX is in phase III of development for the treatment of Peyronie's disease, in phase IIa of development for the treatment of Frozen Shoulder syndrome (Adhesive Capsulitis) and in phase Ib of development for the treatment of cellulite (edematous fibrosclerotic panniculopathy). Auxilium also has rights to pursue additional indications for XIAFLEX. For additional information, visit http://www.auxilium.com.

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

This release contains "forward-looking-statements" within the meaning of The Private Securities Litigation Reform Act of 1995, including statements regarding the Company's intention to present at the 2012 Barclays Capital Global Healthcare Conference; and products in development for Peyronie's disease, Frozen Shoulder syndrome and cellulite; and all other statements containing projections, statements of future performance or expectations, our beliefs or statements of plans or objectives for future operations (including statements of assumption underlying or relating to any of the foregoing). Forward-looking statements can generally be identified by words such as "believe," "appears," "may," "could," "will," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," and other words and terms of similar meaning in connection with any discussion of projections, future performance or expectations, beliefs, plans or objectives for future operations (including statements of assumption underlying or relating to any of the foregoing). Actual results may differ materially from those reflected in these forward-looking statements due to various
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
5. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
6. Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
7. Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue Guidance
8. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
10. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Chek Diagnostics, the U.S.-based manufacturer of both ... diagnostic products, has again been named to the ... in America. The Inc. 5000 ranking is ... Diagnostics earned its place on the list by growing ... For Chek Diagnostics, who appears on the ...
(Date:9/15/2014)... Pa. , Sept. 15, 2014  Inovio Pharmaceuticals, ... it has met the stringent listing criteria for the ... to this U.S. stock exchange from the NYSE MKT. ... ticker symbol, "INO." NASDAQ Global Select ... the highest initial listing standards of any exchange in ...
(Date:9/15/2014)... DUBLIN , Sept. 15, 2014 ... the "Digital Pathology Market by Slide Scanners, Analytics, ... Global Forecasts & Trends to 2018" report to ... the global digital pathology market into different products and ... digital pathology products market, followed by analytics. The analytics ...
Breaking Medicine Technology:Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 3Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 2Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 3Global Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Forecasts & Trends to 2018 2Global Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Forecasts & Trends to 2018 3
... (NASDAQ: GPRO ) announced today that the Company ... Growth Stock Conference in Chicago on June 15, 2011 at ... presentation is scheduled to be webcast live and may be ... website at www.gen-probe.com . The webcast will be available ...
... Educating the critical players in the pharmaceutical marketplace ... been considered a key component of a successful product ... diminished, education efforts have taken on new importance among ... Facing a competitive environment, organizations with new products are ...
Cached Medicine Technology:Gen-Probe to Webcast Presentation at the William Blair & Company 31st Annual Growth Stock Conference 2Educating Key Stakeholders to Support a Successful Pharmaceutical Product Launch 2
(Date:9/16/2014)... (PRWEB) September 16, 2014 The rapidly ... concern for health plans, employers and PBMs as spending ... of their drug lists. Once a concentrated, patient-specific practice, ... 25 webinar from Atlantic Information Services, Inc. (AIS), ... will offer details of what one leading health ...
(Date:9/16/2014)... The Living Ethics lecture series returns ... on what it means to live in an ethically ... and thought-provoking topics. , “The Museum’s job is to ... at their world differently. The Living Ethics series’ ... truly enlightening dialogue,” says Richard Conti, Chief Wonder Officer, ...
(Date:9/16/2014)... Botanica Day Spa ... kicking off September with fall-themed discounts and giveaways. ... chose to highlight lumablanc® which contains Pevonia’s exclusive ... with the skin. , Lumablanc® was recently released ... anti-aging line. The brightening formula, containing a blend ...
(Date:9/16/2014)... Reading, MA (PRWEB) September 16, 2014 ... announce its partnership with Fairfax Egg Bank. The collaboration ... and expand the donor egg offering at the Fertility ... operated since 2006 and offers the nation’s largest selection ... is advantageous for several reasons:, , ...
(Date:9/15/2014)... 2014 With the variety of drugs ... to know the details on each one. However, it ... substances falling into their teen’s hands. , Synthetic ... among high school students. With varied, misleading and potentially ... it can be difficult for parents to separate the ...
Breaking Medicine News(10 mins):Health News:Sept. 25 Webinar to Offer Health Plan, Employer Strategies to Control Compounded Medication Costs 2Health News:Expanding Community Vision at the Science Museum of Virginia 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 3Health News:FCNE Announces Partnership with Fairfax Egg Bank 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 3
... today that the United States Food and,Drug Administration ... first LDL cholesterol lowering medication also indicated for,improving ... mellitus (DM) in,combination with metformin, sulfonylureas, or insulin, ... with other anti-diabetic agents., The ADA estimates ...
... by New York City Mayor,Michael Bloomberg, Lance Armstrong ... discussed Lance,s request to the Surgeons General,Collective to ... "This year alone, 1.4 million Americans are expected ... lose their lives to the disease," said,Lance Armstrong, ...
... Diego Supercomputer Center and other parts of the University ... Disease, fusion energy and climate change - were awarded ... as part of its 2008 Innovative and Novel Computational ... total, the DOEs Office of Science awarded a record ...
... seeds, chemo wafers slowed disease, boosted survival , , ... radioactive seeds and chemotherapy wafers following surgery shows ... study finds. , The early-phase clinical trial, led ... University of Cincinnati and University Hospital, included 34 ...
... Postings Part of Available Resources-, JACKSONVILLE, Fla., ... this group of returning wounded veterans are the ... Project has expanded,their ever-evolving battery of programs and ... (WtoW) initiative., The Warriors to Work (WtoW) ...
... this morning that Chairman and CEO Fred Hassan,intends ... million of Schering-Plough,Common Shares with personal funds., ... I purchased $4.68 million in,Schering-Plough Common Shares at ... this investment in Schering-Plough reflects my long-term,confidence in ...
Cached Medicine News:Health News:MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS 2Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 2Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 3Health News:DOE awards supercomputing time to UCSD, SDSC researchers 2Health News:DOE awards supercomputing time to UCSD, SDSC researchers 3Health News:Combo Therapy Shows Promise in Treating Brain Tumors 2Health News:Wounded Warrior Project (WWP) Expands Service Offerings for Injured Soldiers with the New 'Warriors to Work' Program 2Health News:Schering-Plough CEO to Buy $2 Million in Common Shares 2Health News:Schering-Plough CEO to Buy $2 Million in Common Shares 3
... Laboratories Platelia Aspergillus EIA is a one-stage ... monoclonal antibody EBA-2 to detect circulating galactomannan ... 3 hours. , ,When used in conjunction ... is an aid in the diagnosis of ...
... The GreenLight PV Laser System ... the Prostate) Procedure for the ... (BPH) allows the urologist to ... a TURP with the safety ...
... diagnosis is generally confirmed by a positive heterophil ... however, is not indicated by the heterophil antibody ... - 20 percent of children. Detection and ... fully ascertain the stage of EBV infection. ...
... Bard® Biopsy Instrument and Needle is specially ... goal: a large quality, reliable core sample. ... featuring ultra-sharp tips and polished surfaces for ... of biopsy systems and needle sizes assures ...
Medicine Products: